necitumumab injection\u00a0 is an epidermal growth factor receptor (EGFR) antagonist indicated, in combination with gemcitabine and cisplatin, for first-line treatment of patients with metastatic squamous non-small cell lung cancer.
\nLimitation of Use: necitumumab is not indicated for treatment of non-squamous non-small cell lung cancer.<\/p>\n
If necitumumab injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n","protected":false},"excerpt":{"rendered":"
Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer.\u00a0This medicine has been approved in The US, Canda and Europe. We can get you the US FDA approved stock.<\/p>\n
DISEASE INDICATIONS-Lung Cancer If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cnecitumumab injection\u201d based on the information you provide.<\/p>\n
\nMANUFACTURER-Eli Lilly Nederland B.V.
\nUSAGE-Intravenous
\nMEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n